|
Market Closed -
NSE India S.E.
12:05:09 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 903.20 INR | -2.36% |
|
-5.04% | +28.62% |
| Market Cap | 10.64B 111M 97.75M 92.61M 83.61M 158M 160M 1.11B 426M 5.44B 417M 408M 17.44B | P/E 2025 |
45.4x | P/E 2026 | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 10.36B 108M 95.19M 90.19M 81.42M 153M 155M 1.08B 415M 5.3B 406M 397M 16.99B | EV / Sales 2025 |
2.12x | EV / Sales 2026 | 0.82x |
| Free-Float |
24.75% | Yield 2025 |
0.07% | Yield 2026 | 0.16% |
| 1 day | -2.36% | ||
| 1 week | -5.04% | ||
| Current month | +0.42% | ||
| 1 month | -2.36% | ||
| 3 months | +18.29% | ||
| 6 months | +47.40% | ||
| Current year | +28.62% |
| 1 week | 882 | 969.95 | |
| 1 month | 835.1 | 1,007 | |
| Current year | 580 | 1,007 | |
| 1 year | 580 | 1,007 | |
| 3 years | 580 | 1,417.38 | |
| 5 years | 213.91 | 1,417.38 | |
| 10 years | 213.91 | 1,417.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 39 | 15/01/2023 | |
Bhavik Shah
DFI | Director of Finance/CFO | - | 08/07/2026 |
| Compliance Officer | - | 05/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 39 | 20/09/2015 | |
| Chairman | 41 | 20/09/2015 | |
| Director/Board Member | 38 | 20/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.36% | -5.04% | +22.98% | +41.93% | 114M | ||
| -0.05% | +2.15% | +54.10% | +118.43% | 1,056B | ||
| -0.10% | -0.69% | +44.17% | +72.30% | 645B | ||
| +0.20% | -0.49% | +13.92% | +77.93% | 465B | ||
| -1.70% | -1.26% | +74.22% | +42.58% | 368B | ||
| -0.06% | -3.88% | +34.32% | +40.74% | 335B | ||
| -0.79% | +2.01% | +19.82% | +28.48% | 275B | ||
| -1.19% | -1.21% | +9.82% | +12.15% | 255B | ||
| -0.06% | +4.06% | +49.74% | +58.68% | 229B | ||
| -0.75% | -0.89% | +35.15% | +102.46% | 188B | ||
| Average | -0.63% | -0.16% | +35.82% | +59.57% | 381.59B | |
| Weighted average by Cap. | -0.34% | +0.30% | +41.11% | +73.60% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 6.2B 64.7M 56.97M 53.98M 48.73M 91.85M 93.04M 646M 249M 3.17B 243M 238M 10.17B | 8.54B 89.03M 78.4M 74.28M 67.06M 126M 128M 889M 342M 4.36B 334M 327M 13.99B |
| Net income | 291M 3.03M 2.67M 2.53M 2.28M 4.3M 4.36M 30.26M 11.65M 149M 11.38M 11.14M 476M | 370M 3.86M 3.4M 3.22M 2.91M 5.48M 5.55M 38.51M 14.82M 189M 14.49M 14.17M 606M |
| Net Debt | -42.9M -447K -394K -373K -337K -635K -643K -4.47M -1.72M -21.93M -1.68M -1.64M -70.31M | -278M -2.9M -2.56M -2.42M -2.19M -4.12M -4.18M -28.98M -11.15M -142M -10.9M -10.67M -456M |
Employees
69
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | ₹903.20 | -2.36% | 5,400 |
| 29/09/26 | ₹925.05 | +0.60% | 4,200 |
| 28/09/26 | ₹919.50 | -2.80% | 4,200 |
| 25/09/26 | ₹946.00 | +0.40% | 2,700 |
| 24/09/26 | ₹942.20 | -3.59% | 4,200 |
- Stock Market
- Stocks
- REMUS Stock
Select your edition
All financial news and data tailored to specific country editions
















